David C. Harmes

Direct Identification of Rituximab Main Isoforms and Subunit Analysis by Online Selective Comprehensive Two-Dimensional Liquid Chromatography–Mass Spectrometry

Dwight R. Stoll, David C. Harmes, John Danforth et al. · Analytical Chemistry · 2015 · 105 citations

Development of Comprehensive Online Two-Dimensional Liquid Chromatography/Mass Spectrometry Using Hydrophilic Interaction and Reversed-Phase Separations for Rapid and Deep Profiling of Therapeutic Antibodies

Dwight R. Stoll, David C. Harmes, Gregory O. Staples et al. · Analytical Chemistry · 2018 · 97 citations

Molecular Biology, Peptide Science, Analytical Ultracentrifugation +28

Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry

Matthew D. Sorensen, David C. Harmes, Dwight R. Stoll et al. · mAbs · 2016 · 87 citations · Full text

Time-of-flight Mass Spectrometry, Immunology, Immunotherapy +22

Positive and negative regulation of ΔN-p63 promoter activity by p53 and ΔN-p63-α contributes to differential regulation of p53 target genes

David C. Harmes, Edward Bresnick, Emma A. Lubin et al. · Oncogene · 2003 · 83 citations

Transcriptional Regulation, P53 Target Genes, δN-p63-α Contributes +13

Evaluation of detection sensitivity in comprehensive two-dimensional liquid chromatography separations of an active pharmaceutical ingredient and its degradants

Dwight R. Stoll, Eric S. Talus, David C. Harmes et al. · Analytical and Bioanalytical Chemistry · 2014 · 76 citations

Medicinal Chemistry, Active Pharmaceutical Ingredient, Separation Science +13